Published on 22 Aug 2022 on KCRG-TV9 Cedar Rapids
Prominent ophthalmologist will guide Turn Bio's search for therapies to cure eye diseases
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure...
Prominent ophthalmologist will guide Turn Bio's search for therapies to cure eye diseases
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines to cure...
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday By Benzinga
Why GigaCloud Technology Jumped 206%; Here Are 79 Biggest Movers From Yesterday
Sight Sciences Grows Portfolio Amid Reimbursement Pressure (NASDAQ:SGHT)
Sight Sciences went public in July 2021, raising $240 million in an IPO. The firm develops and se...
Sight Sciences, Inc. (SGHT) Q2 2022 Earnings Call Transcript
Presenting today are Sight Sciences co-founder and chief executive officer, Paul Badawi; and chie...
Doximity (DOCS) to Report Q1 Earnings: What's in the Offing?
Doximity, Inc. DOCS is scheduled to report first-quarter fiscal 2023 results on Aug 4, after the ...
Council Post: Advancing Artificial Intelligence And Creating The Technology Of The Future
The global artificial intelligence (AI) market is expected to reach the trillion-dollar mark by...
BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?
Becton Dickinson and Company BDX, popularly known as BD, is scheduled to report third-quarter fis...
Univec, Inc. (OTCMKTS:UNVC) Sees Large Drop in Short Interest
Univec, Inc. (OTCMKTS:UNVC – Get Rating) saw a significant decrease in short interest in July. As...
Public records for the week of May 16
View the latest commercial property transactions in Hampton Roads.
Atlanta startups see drop in funding during April
In April of last year, Atlanta startups raised more than $725 million, including local unicorns O...